Hints and tips:
Related Special Reports
Companies have yet to provide investors with convincing post-pandemic strategies
The FT’s fourth annual ranking of the region’s businesses by revenue growth. Plus: companies with the ‘last-mover advantage’; cannabis corporations on the rise; is Moderna a one trick pony?
...insurance scheme],” said Robert Przybelski, a geriatrician at UW Health in Madison, Wisconsin, where about 25 patients have been treated with the drug....
...Pfizer and BioNTech will dispute Moderna’s ability to withdraw the pledge when it did, given the World Health Organization did not declare the end of the “global health emergency” until March 2023....
...The country’s National Institute for Health and Care Excellence, the public health body, recommends the drug be used only for people with serious underlying health conditions such as cancer and HIV or recipients...
Regulator authorises treatment for sickle cell disease and beta thalassaemia
...WhatsApp to Susan: OK look there’s a chance Labour’s shadow health or science secretaries may drop into these meetings so we can’t just ask the usual types. We need expertise....
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
...Biotech beauty products are increasingly filling our bathroom cabinets; the science may have been used in a simple way for decades, but new innovations are driving considerable change....
...The findings will raise concerns about the effectiveness of antiviral drugs to treat Covid-19 as health authorities prepare for a busy autumn after a rise in cases driven by Omicron subvariants with a large...
...Given your briefs in health and science, I just wanted to give you an early sight of a paper we are putting out — an AI manifesto for the NHS. We’ve called it Help is on the WAI....
...Roivant Sciences, which has a portfolio of companies, was founded in 2014 by Vivek Ramaswamy, who is now running for US president....
...He said chancellor Jeremy Hunt and the health department should address conflicts with the pharmaceutical industry over drug prices and hurdles to running clinical trials in the NHS....
...“Vaccination remains critical to public health and continued protection against serious consequences of Covid-19, including hospitalisation and death,” said Peter Marks, director of the FDA’s Center for...
...For many farmers, regenerative agriculture is more to do with the health of their land than of their bank balances....
...Results were published on Thursday in the journal Science....
...“Thaysen is a top leader at one of the top five life science companies and is well known by the life sciences and technology investor base . . . which should help on the communication front.”...
BNP Paribas joins environmentalists in pressing companies to run toxin tests with synthetic substances
...The high price of the drugs — lecanemab is priced at $26,500 per year — and tough restrictions imposed by the US government on reimbursement by publicly funded health schemes for amyloid-reducing treatments...
Pharmaceutical and biotech deals are rebounding after a dip last year
...of the FDA’s Center for Tobacco Products’ Office of Science....
...Some emerging health science companies aspire to be the next Amgen, which has a market capitalisation of $120bn....
...Geraldine Thomas, a radiation health expert at Imperial College London who has visited Fukushima five times since the accident, agreed....
FTC warns acquisition would hurt competition in the market for early detection cancer tests
...Both Read and Sadoun agree some jobs will disappear but say many others — in data sciences, programming and analytics — will be created. “We don’t have all the answers yet,” says Read....
International Edition